10:11 AM EDT, 08/15/2024 (MT Newswires) -- AbbVie ( ABBV ) said Thursday that Epkinly is now reimbursable in Ontario and Quebec, Canada as a treatment for adult patients with relapsed or refractory diffuse large B-cell lymphoma, subject to certain criteria.
The company said the reimbursement is under Ontario Health (Cancer Care Ontario) and the Quebec Health Insurance Board.
Price: 192.77, Change: -0.24, Percent Change: -0.12